These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
325 related articles for article (PubMed ID: 23474817)
21. Friedreich's Ataxia: from the (GAA)n repeat mediated silencing to new promising molecules for therapy. Marmolino D; Acquaviva F Cerebellum; 2009 Sep; 8(3):245-59. PubMed ID: 19165552 [TBL] [Abstract][Full Text] [Related]
22. Generation and characterization of iPSC lines from Friedreich's ataxia patient (FRDA) with GAA.TTC repeat expansion in the Frataxin (FXN) gene's first intron (IGIBi016-A) and a non-FRDA healthy control individual (IGIBi017-A). Ahmad I; Kamai A; Zahra S; Kapoor H; Kumar Srivastava A; Faruq M Stem Cell Res; 2024 Jun; 77():103382. PubMed ID: 38484450 [TBL] [Abstract][Full Text] [Related]
23. Epigenetic and neurological effects and safety of high-dose nicotinamide in patients with Friedreich's ataxia: an exploratory, open-label, dose-escalation study. Libri V; Yandim C; Athanasopoulos S; Loyse N; Natisvili T; Law PP; Chan PK; Mohammad T; Mauri M; Tam KT; Leiper J; Piper S; Ramesh A; Parkinson MH; Huson L; Giunti P; Festenstein R Lancet; 2014 Aug; 384(9942):504-13. PubMed ID: 24794816 [TBL] [Abstract][Full Text] [Related]
24. Excision of the expanded GAA repeats corrects cardiomyopathy phenotypes of iPSC-derived Friedreich's ataxia cardiomyocytes. Li J; Rozwadowska N; Clark A; Fil D; Napierala JS; Napierala M Stem Cell Res; 2019 Oct; 40():101529. PubMed ID: 31446150 [TBL] [Abstract][Full Text] [Related]
25. MutLα heterodimers modify the molecular phenotype of Friedreich ataxia. Ezzatizadeh V; Sandi C; Sandi M; Anjomani-Virmouni S; Al-Mahdawi S; Pook MA PLoS One; 2014; 9(6):e100523. PubMed ID: 24971578 [TBL] [Abstract][Full Text] [Related]
26. Complete FXN deletion in a patient with Friedreich's ataxia. van den Ouweland AM; van Minkelen R; Bolman GM; Wouters CH; Becht-Noordermeer C; Deelen WH; Deelen-Manders JM; Ippel EP; Saris J; Halley DJ Genet Test Mol Biomarkers; 2012 Sep; 16(9):1015-8. PubMed ID: 22691228 [TBL] [Abstract][Full Text] [Related]
27. Generation of two human induced pluripotent stem cell lines, IGIBi012-A and IGIBi013-A from Friedreich's ataxia (FRDA) patients with homozygous GAA repeat expansion in FXN gene. Ahmad I; Kapoor H; Srivastava AK; Faruq M Stem Cell Res; 2024 Apr; 76():103340. PubMed ID: 38367363 [TBL] [Abstract][Full Text] [Related]
28. Somatic instability of the expanded GAA repeats in Friedreich's ataxia. Long A; Napierala JS; Polak U; Hauser L; Koeppen AH; Lynch DR; Napierala M PLoS One; 2017; 12(12):e0189990. PubMed ID: 29261783 [TBL] [Abstract][Full Text] [Related]
29. HDAC inhibitors correct frataxin deficiency in a Friedreich ataxia mouse model. Rai M; Soragni E; Jenssen K; Burnett R; Herman D; Coppola G; Geschwind DH; Gottesfeld JM; Pandolfo M PLoS One; 2008 Apr; 3(4):e1958. PubMed ID: 18463734 [TBL] [Abstract][Full Text] [Related]
30. Reversal of epigenetic promoter silencing in Friedreich ataxia by a class I histone deacetylase inhibitor. Chutake YK; Lam CC; Costello WN; Anderson MP; Bidichandani SI Nucleic Acids Res; 2016 Jun; 44(11):5095-104. PubMed ID: 26896803 [TBL] [Abstract][Full Text] [Related]
31. Mechanism of Action of 2-Aminobenzamide HDAC Inhibitors in Reversing Gene Silencing in Friedreich's Ataxia. Soragni E; Chou CJ; Rusche JR; Gottesfeld JM Front Neurol; 2015; 6():44. PubMed ID: 25798128 [TBL] [Abstract][Full Text] [Related]
32. Mitochondrial damage and senescence phenotype of cells derived from a novel frataxin G127V point mutation mouse model of Friedreich's ataxia. Fil D; Chacko BK; Conley R; Ouyang X; Zhang J; Darley-Usmar VM; Zuberi AR; Lutz CM; Napierala M; Napierala JS Dis Model Mech; 2020 Jul; 13(7):. PubMed ID: 32586831 [TBL] [Abstract][Full Text] [Related]